Canadian Plastics

W. R. Grace builds pharma and consumer portfolio with Fine Chemistry Services acquisition

Canadian Plastics   


The transaction is valued at approximately $570 million, including $300 million in cash.

Chemicals company W. R. Grace & Co. has acquired the Fine Chemistry Services (FCS) business of chemical supplier Albemarle Corp.

The transaction is valued at approximately US$570 million, including US$300 million in cash and US$270 million funded through the issuance to Albemarle of non-participating preferred equity of a newly created Grace subsidiary.

“FCS brings compelling innovation and manufacturing capabilities to our Materials Technologies business, enabling us to better serve our customers with high-value solutions that span every stage of their development cycle,” said Hudson La Force, Grace’s president and CEO, in a news release.

Pharma and consumer are described as being the largest, fastest growing and most profitable subsegment within Grace’s Materials Technologies business, the news release continued. “FCS adds a comprehensive portfolio of high-value products and services with highly complementary analytical, regulatory and manufacturing capabilities to [our] existing pharma portfolio focused on chromatographic resins, formulation excipients and drug delivery, pharmaceutical intermediates and active pharmaceutical ingredients,” it said.


W.R. Grace is headquartered in Columbia, Maryland.


Stories continue below

Print this page

Related Stories